Inflexion
Inflexion_25Years
Menu

Lintbells

Inflexion invested in Lintbells, a globally recognised leader in pet supplements in 2017, before selling it in 2024 to Vetnique Labs, backed by Gryphon Investors.

  • Sector

    Healthcare, Consumer

  • Headquarters

    Weston, UK

  • Fund

    Enterprise

  • Investment date

    December 2017 - July 2024

  • Status

    Realised


The company 

Hertfordshire, UK-based Lintbells was founded almost two decades ago by Dr John Howie DL and John Davies, to provide pets and their owners with scientifically supported supplements to support chronic health conditions. Lintbells’ products are sold under the YuMOVE brand umbrella, encompassing the UK’s number one joint mobility supplement for dogs and cats, as well as supplements to support digestive health, anxiety, skin & coat and dental.

The Inflexion investment

Since the 2017 investment, Inflexion’s in-house teams have supported Lintbells across a range of growth opportunities, including the expansion of its highly successful direct-to-consumer channel. Inflexion has also facilitated Lintbells' successful expansion into the US, both organically and through the acquisition of Walkin’ Pets.

The Inflexion difference

Inflexion supported Lintbells to achieve B Corp accreditation, reflecting its impressive ESG achievements. The partnership also facilitated the planned succession of Co-founder John Howie, who set the business up in 2006, with Fiona Hope brought in as Chief Commercial Officer shortly after the Inflexion investment and taking over as CEO in 2022.

Press releases